Cardiovascular disease & stroke
Prevention, acute care, rehabilitation, risk-factor control, access, outcomes, and implementation gaps.
The American Renewal Plan · Health & Medicine
Health & Medicine
A public evidence hub for improving health outcomes in the United States. The goal is to distinguish what is promising from what is proven, what has failed, what is safe, what remains uncertain, and which system barriers keep effective care from reaching people.
How to read this section
This section separates prevention, symptom control, disease modification, remission, and cure. It also records negative evidence, failed trials, safety limitations, durability, access barriers, cost, and the next experiment or policy test that could resolve uncertainty.
Medical safety: this site provides public evidence and policy analysis, not individualized medical advice. It does not tell readers to start, stop, or change prescriptions, diets, supplements, devices, procedures, or experimental treatments.
Major U.S. burden areas
Cancer
U.S. burden, prevention, screening, access, cost, survivorship, and system policy. Global discovery evidence remains in its separately governed project rather than being duplicated here.
Metabolic disease
Diabetes, obesity, kidney disease, liver disease, prevention, remission evidence, affordability, and long-term outcomes.
Brain & mental health
Neurodegeneration, ADHD, depression, suicide prevention, addiction, evidence quality, safety, and access to effective care.
Respiratory & digestive health
Chronic respiratory disease, reflux/GERD, inflammatory and immune-mediated disease, treatment durability, and quality-of-life outcomes.
Preventable injury & overdose
Falls, traffic injury, overdose, emergency care, prevention programs, and measurable community outcomes.
Disease-modifying research watch
Responsible America tracks high-value research where the objective is more than temporary symptom control. Priority examples include immune tolerance and disease modification in celiac disease, durable ADHD treatment/remission pathways, full-lifespan GERD remission strategies, and cross-disease platforms such as mRNA and immunotherapy where the biology and evidence justify them.
Every research record should identify evidence stage, trial design, sample size, efficacy endpoint, durability, adverse effects, delivery limitations, regulatory status, negative evidence, strongest alternative explanation, decisive next experiment, and falsifier.
What the health system must answer
- Which interventions measurably reduce disease, disability, premature death, and avoidable suffering?
- Which promising approaches failed, and why?
- How much of the gap is scientific versus access, price, insurance design, workforce, geography, or implementation?
- Where do U.S. outcomes lag credible international comparators, and what explains the difference?
- Which reforms can be measured with clear baselines, owners, costs, tradeoffs, and outcome targets?
Evidence standard
Current medical claims should be traced to peer-reviewed research, authoritative trial registries, regulators, major research institutions, and other primary or high-quality evidence. News is useful for discovery, not as the final proof layer. High-impact medical claims remain fail-closed and require stronger review before publication.
See Research, Evidence & Corrections for the platform-wide evidence method.